OMIC

Singular Genomics Systems, Inc. Common Stock

Delisted

OMIC was delisted on the 20th of February, 2025.

69 hedge funds and large institutions have $259M invested in Singular Genomics Systems, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$28.1M
2 +$10.7M
3 +$4.46M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.46M
5
PA
Perceptive Advisors
New York
+$2.03M

Top Sellers

1 -$18.9M
2 -$15.8M
3 -$4.65M
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.07M
5
TM
Triatomic Management
California
-$1.69M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$966K
27
$895K
28
$693K
29
$631K
30
$618K
31
$602K
32
$579K
33
$576K
34
$553K
35
$513K
36
$396K
37
$333K
38
$326K
39
$230K
40
$199K
41
$193K
42
$172K
43
$167K
44
$160K
45
$159K
46
$148K
47
$135K
48
$127K
49
$126K
50
$124K